Hyderabad Telangana, India

Venkataraman Sundaram

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkataraman Sundaram. Retrieved from https://idiyas.com/inventor/venkataraman-sundaram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Venkataraman Sundaram: Pharmaceutical Process Inventor

Introduction

Venkataraman Sundaram is an inventor based in Hyderabad, Telangana, India. His patent work includes processes for preparing pharmaceutical compounds, including voriconazole and montelukast. He is associated with Dr. Reddy’s Laboratories, Incorporated, and holds 2 patents.

Latest Patents

One of Sundaram’s patents describes a process for preparing voriconazole. The process condenses 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)ethanone with 4-chloro-6-ethyl-5-fluoropyrimidine in a specified solvent, producing an intermediate used in the preparation of the antifungal compound.

Another patent concerns the preparation of montelukast and its pharmaceutically acceptable salts. The disclosed process involves a compound represented by formula (VI), in which X is CN or CONH.

Career Highlights

Sundaram’s listed inventions focus on pharmaceutical manufacturing processes and the preparation of established medicines. His work is associated with Dr. Reddy’s Laboratories, a pharmaceutical company.

Collaborations

Sanjeev Kumar Aavula and AlokKumar Srivastav are identified as Sundaram’s coworkers.

Conclusion

Venkataraman Sundaram’s patent portfolio reflects contributions to pharmaceutical process development, particularly methods related to voriconazole and montelukast.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…